What to Read: John Castellani on America's Export Economy

What to Read: John Castellani on America's Export Economy

12.13.11 | By Kate Connors

In The Hill's CongressBlog, PhRMA President and CEO John J. Castellani had an op-ed today about how our federal efforts to stimulate economic growth will undoubtedly lack the momentum they need without a related emphasis on exports - and the biopharmaceutical sector, already a major generator of exports, can help. But we need support.
He writes: "Leadership is needed to help keep U.S. biopharmaceutical research companies competitive in the global export market. For example, stronger IP rights and enforcement are essential. U.S. biopharmaceutical research companies must have confidence that their property - their ideas and innovations and the product of billions of dollars in investment - will not be stolen."
He also discusses the Korea-U.S. Free Trade Agreement, recently signed into law by President Obama, as a highlight of policies that can help protect IP-intensive sectors while still opening the door to trade.
In an increasingly global economy, we can't close our eyes to the world around us. If America's businesses are to grow, they need to have the ability to grow around the world.

More On PhRMA — powered by PhRMApedia


Cost in Context